Company Performance - Dow Inc. (DOW) stock increased by 2.78% to $30.73, outperforming the S&P 500's daily loss of 0.43% [1] - Over the past month, DOW's stock has risen by 10.09%, surpassing the Basic Materials sector's gain of 7.73% and the S&P 500's loss of 0.5% [1] Upcoming Earnings - The upcoming EPS for Dow Inc. is projected at -$0.33, indicating a significant drop of 1,750.00% compared to the same quarter last year [2] - The Zacks Consensus Estimate for revenue is expected to be $9.42 billion, reflecting a decrease of 9.7% from the previous year [2] Full-Year Estimates - Full-year Zacks Consensus Estimates predict earnings of -$0.18 per share and revenue of $39.25 billion, representing year-over-year changes of +80.85% and -1.8%, respectively [3] - Recent changes in analyst estimates for Dow Inc. indicate a dynamic business environment, with positive revisions suggesting increased confidence in performance and profit potential [3] Zacks Rank and Industry Performance - The Zacks Rank system, which ranges from 1 (Strong Buy) to 5 (Strong Sell), has shown that 1 stocks have delivered an average annual return of +25% since 1988 [5] - Dow Inc. currently holds a Zacks Rank of 3 (Hold), with a recent upward shift of 19.86% in the Zacks Consensus EPS estimate over the past month [5] Industry Context - The Chemical - Diversified industry, part of the Basic Materials sector, has a Zacks Industry Rank of 169, placing it in the bottom 32% of over 250 industries [6] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [6]

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.While many investors like to look for momentum i ...

Key Takeaways ALB ended 2025 with $3.2B liquidity and operating cash flow up 86% year over year.Albemarle generated $692M free cash flow in 2025 and sees meaningful gains in 2026.ALB has raised dividends for 30 straight years and offers a 0.8% yield.Albemarle Corporation (ALB) remains committed to driving shareholder value by leveraging solid liquidity and healthy cash flows. At the end of 2025, ALB had liquidity of around $3.2 billion, including cash and cash equivalents of around $1.6 billion. Its operati ...

The Basic Materials group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Compass Minerals (CMP) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the company's year-to-date performance in comparison to the rest of the Basic Materials sector should help us answer this question.Compass Minerals is one of 254 individual stocks in the Bas ...

Stepan Co. (SCL) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of $0.35. This compares to earnings of $0.12 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -105.71%. A quarter ago, it was expected that this specialty chemicals company would post earnings of $0.36 per share when it actually produced earnings of $0.48, delivering a surprise of +33.33%.Over the last four quarters, the compa ...

分组1 - Chemours reported quarterly earnings of $0.05 per share, exceeding the Zacks Consensus Estimate of breakeven, but down from $0.11 per share a year ago, representing an earnings surprise of +2,400.00% [1] - The company posted revenues of $1.33 billion for the quarter ended December 2025, aligning with the Zacks Consensus Estimate, but down from $1.36 billion year-over-year [2] - Chemours shares have increased approximately 79.4% since the beginning of the year, significantly outperforming the S&P 500's gain of 0.5% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is $0.20 on revenues of $1.43 billion, and for the current fiscal year, it is $1.70 on revenues of $6.04 billion [7] - The Zacks Industry Rank for Chemical - Diversified is currently in the bottom 23% of over 250 Zacks industries, indicating potential underperformance compared to higher-ranked industries [8] - The estimate revisions trend for Chemours was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, suggesting expected underperformance in the near future [6]

分组1 - Tronox reported a quarterly loss of $0.6 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.43, and a significant decline from earnings of $0.03 per share a year ago, indicating an earnings surprise of -38.38% [1] - The company posted revenues of $730 million for the quarter ended December 2025, slightly missing the Zacks Consensus Estimate by 0.03%, and showing an increase from $676 million in the same quarter last year [2] - Over the last four quarters, Tronox has consistently failed to surpass consensus EPS and revenue estimates, indicating ongoing challenges in meeting market expectations [2] 分组2 - The stock's immediate price movement will largely depend on management's commentary during the earnings call, as the sustainability of its performance is uncertain [3][4] - Despite the poor earnings report, Tronox shares have increased by approximately 82.3% since the beginning of the year, outperforming the S&P 500, which has shown no return [3] - The current consensus EPS estimate for the upcoming quarter is -$0.31 on revenues of $739.87 million, and for the current fiscal year, it is -$0.72 on revenues of $2.91 billion [7] 分组3 - The Zacks Industry Rank places the Chemical - Diversified sector in the bottom 21% of over 250 Zacks industries, suggesting that the overall industry outlook may negatively impact Tronox's stock performance [8] - The unfavorable trend in estimate revisions prior to the earnings release has resulted in a Zacks Rank of 5 (Strong Sell) for Tronox, indicating expectations of underperformance in the near future [6]

Core Insights - Momentum investing focuses on following a stock's recent price trends, with the aim of buying high and selling higher, capitalizing on established price movements [1] - The Zacks Momentum Style Score helps investors identify stocks with momentum, addressing the challenges of defining momentum in stocks [2] Company Overview: Compass Minerals (CMP) - Compass Minerals currently holds a Momentum Style Score of B and a Zacks Rank of 1 (Strong Buy), indicating strong potential for outperformance [3][4] - CMP shares have increased by 10.3% over the past week, outperforming the Zacks Chemical - Diversified industry, which rose by 3.42% during the same period [6] - Over the past quarter, CMP shares have risen by 23.73%, and over the last year, they have increased by 92.42%, significantly outperforming the S&P 500's gains of 2.88% and 13.25%, respectively [7] Trading Volume and Market Sentiment - CMP's average 20-day trading volume is 514,620 shares, which serves as a bullish indicator when combined with rising stock prices [8] Earnings Outlook - In the past two months, one earnings estimate for CMP has increased, raising the consensus estimate from $0.70 to $0.80 for the full year, with no downward revisions [10] - For the next fiscal year, one estimate has also moved upwards, indicating positive sentiment regarding future earnings [10] Conclusion - Given the strong performance metrics and positive earnings outlook, CMP is positioned as a solid momentum pick for investors seeking short-term opportunities [12]

分组1 - Innospec reported quarterly earnings of $1.5 per share, exceeding the Zacks Consensus Estimate of $1.26 per share, and showing an increase from $1.41 per share a year ago, resulting in an earnings surprise of +19.05% [1] - The company posted revenues of $455.6 million for the quarter ended December 2025, which was 4.39% below the Zacks Consensus Estimate and a decrease from $466.8 million year-over-year [2] - Innospec has surpassed consensus EPS estimates in all four of the last quarters and has topped consensus revenue estimates two times during the same period [2] 分组2 - The stock has increased approximately 13.1% since the beginning of the year, while the S&P 500 has declined by 0.1% [3] - The current consensus EPS estimate for the upcoming quarter is $1.35, with expected revenues of $460.6 million, and for the current fiscal year, the estimate is $5.71 on $1.88 billion in revenues [7] - The Zacks Industry Rank for Chemical - Diversified is in the bottom 18% of over 250 Zacks industries, indicating potential challenges for stock performance compared to higher-ranked industries [8]

分组1 - Huntsman reported a quarterly loss of $0.37 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.29, and compared to a loss of $0.25 per share a year ago, indicating an earnings surprise of -25.68% [1] - The company posted revenues of $1.36 billion for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 2.04%, but down from $1.45 billion in the same quarter last year [2] - Huntsman shares have increased by approximately 32.1% since the beginning of the year, while the S&P 500 has declined by 0.1% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is -$0.12 on revenues of $1.41 billion, and for the current fiscal year, it is -$0.30 on revenues of $5.83 billion [7] - The Zacks Industry Rank for Chemical - Diversified is currently in the bottom 18% of over 250 Zacks industries, indicating that the outlook for the industry can significantly impact stock performance [8]